Correlation Between Ioneer and Conduit Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Ioneer and Conduit Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ioneer and Conduit Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ioneer Ltd American and Conduit Pharmaceuticals, you can compare the effects of market volatilities on Ioneer and Conduit Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ioneer with a short position of Conduit Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ioneer and Conduit Pharmaceuticals.

Diversification Opportunities for Ioneer and Conduit Pharmaceuticals

0.2

Correlation Coefficient

Ioneer  Conduit Pharmaceuticals

Modest diversification

The 3 months correlation between Ioneer and Conduit is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding ioneer Ltd American and Conduit Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Conduit Pharmaceuticals and Ioneer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ioneer Ltd American are associated (or correlated) with Conduit Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Conduit Pharmaceuticals has no effect on the direction of Ioneer i.e., Ioneer and Conduit Pharmaceuticals go up and down completely randomly.

Pair Corralation between Ioneer and Conduit Pharmaceuticals

Given the investment horizon of 90 days ioneer Ltd American is expected to generate 0.23 times more return on investment than Conduit Pharmaceuticals. However, ioneer Ltd American is 4.43 times less risky than Conduit Pharmaceuticals. It trades about -0.09 of its potential returns per unit of risk. Conduit Pharmaceuticals is currently generating about -0.06 per unit of risk. If you would invest  455.00  in ioneer Ltd American on October 8, 2024 and sell it today you would lose (34.00) from holding ioneer Ltd American or give up 7.47% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	84.21%
Values	Daily Returns

ioneer Ltd American  vs.  Conduit Pharmaceuticals

ioneer American

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ioneer Ltd American has generated negative risk-adjusted returns adding no value to investors with long positions. Even with fragile performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Conduit Pharmaceuticals

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Conduit Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Conduit Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Ioneer and Conduit Pharmaceuticals

The main advantage of trading using opposite Ioneer and Conduit Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ioneer position performs unexpectedly, Conduit Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Conduit Pharmaceuticals will offset losses from the drop in Conduit Pharmaceuticals' long position.

The idea behind ioneer Ltd American and Conduit Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.